深部脑刺激治疗肌张力障碍:迈向基于网络的个性化治疗
肌张力障碍是累及皮质-基底节-小脑环路的网络性疾病,DBS对药物难治性患者有效但疗效差异大。无创神经生理、术中记录和连接组影像揭示DBS通过调节分布式运动环路起作用,结合临床、遗传、电生理和网络连接特征可优化患者选择和个体化神经调控。
要点
- DBS对药物难治性肌张力障碍有效,但临床结局差异显著。
- 疗效差异源于临床表现、遗传背景和运动控制网络的异质性。
- 整合临床、遗传、电生理和连接组变量有助于个体化DBS策略。
核心结论
- DBS通过调节分布式运动环路而非单一解剖靶点改善肌张力障碍,结合多维度变量可支持个体化神经调控。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- 肌张力障碍是涉及皮质-基底节-小脑环路异常交互的网络性疾病。
- DBS疗效差异与临床表现、遗传背景和受累脑网络异质性有关。
- 无创神经生理技术、术中记录和连接组神经影像揭示DBS调节病理网络。
- 个体反应和长期结局由临床、遗传、神经生理异常和分布式网络连接交互塑造。
临床怎么用
- 结合临床、遗传、神经生理和网络连接变量可优化DBS患者选择。
- 上述变量整合有助于制定个体化神经调控策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dystonia is a complex movement disorder that can cause functional disability and reduce quality of life. Deep brain stimulation (DBS) provides meaningful benefits in patients with medically refractory dystonia, but clinical outcomes can vary substantially. This variability likely reflects the heterogeneity in clinical presentations, genetic background, and brain networks involved in motor control. Dystonia is a network disorder involving abnormal interactions across cortico-basal ganglia-cerebellar circuits. Therapeutic effects of DBS therefore arise from modulation of distributed motor circuits rather than a single anatomical target. Advances in non-invasive neurophysiological techniques, intraoperative recordings, and connectome-based neuroimaging have provided new insights into how DBS modulates these pathological networks. Individual response to DBS and long-term outcomes are shaped by the interaction between clinical and genetic factors, neurophysiological abnormalities, and distributed network connectivity. Combining these variables can help refine patient selection for clinical studies and support individualised neuromodulation strategies.
引用
- Latorre A, Peall KJ, Horn A, et al. Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care. Lancet Neurol. 2026. PMID: 42456686. doi:10.1016/S1474-4422(26)00192-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。